BioHarvest Sciences Inc. CNVCF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

35/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

BioHarvest Sciences Inc. (CNVCF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 34/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

35/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

✓

未來

100/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

43/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — CNVCF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率6.73

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.93

每股账面价值$0.00

每股营收$0.94

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2014	$-0.02	$0.00	$-201.02K	-
2015	$-0.01	$0.00	$-131.76K	-
2016	$0.00	$40K	$-3.5M	-8747.5%
2017	$0.00	$325K	$-1.85M	-568%
2018	$-16.80	$449K	$-6.67M	-1486.2%
2019	$-1.80	$218K	$-5.31M	-2435.8%
2020	$-0.68	$396K	$-6.58M	-1662.6%
2021	$-0.79	$2.1M	$-9.83M	-467.5%
2022	$-0.86	$5.5M	$-11.24M	-204.4%
2023	$-0.93	$12.67M	$-12.56M	-99.1%